Autophagy inhibition prevents glucocorticoid-increased adiposity via suppressing BAT whitening

The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell features defined as BAT whitening under certain circumstances. The aim of our current study was to investigate the possibility and mechanisms o...

Full description

Saved in:
Bibliographic Details
Published inAutophagy Vol. 16; no. 3; pp. 451 - 465
Main Authors Deng, Jiali, Guo, Yajie, Yuan, Feixiang, Chen, Shanghai, Yin, Hanrui, Jiang, Xiaoxue, Jiao, Fuxin, Wang, Fenfen, Ji, Hongbin, Hu, Guohong, Ying, Hao, Chen, Yan, Zhai, Qiwei, Xiao, Fei, Guo, Feifan
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 03.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell features defined as BAT whitening under certain circumstances. The aim of our current study was to investigate the possibility and mechanisms of GC-induced BAT whitening. Here, we showed that one-week dexamethasone (Dex) treatment induced BAT whitening, characterized by lipid droplet accumulation, in vitro and in vivo. Furthermore, autophagy and ATG7 (autophagy related 7) expression was induced in BAT by Dex, and treatment with the autophagy inhibitor chloroquine or adenovirus-mediated ATG7 knockdown prevented Dex-induced BAT whitening and fat mass gain. Moreover, Dex-increased ATG7 expression and autophagy was mediated by enhanced expression of BTG1 (B cell translocation gene 1, anti-proliferative) that stimulated activity of CREB1 (cAMP response element binding protein 1). The importance of BTG1 in this regulation was further demonstrated by the observed BAT whitening in adipocyte-specific BTG1-overexpressing mice and the attenuated Dex-induced BAT whitening and fat mass gain in mice with BTG1 knockdown in BAT. Taken together, we showed that Dex induces a significant whitening of BAT via BTG1- and ATG7-dependent autophagy, which might contribute to Dex-increased adiposity. These results provide new insights into the mechanisms underlying GC-increased adiposity and possible strategy for preventing GC-induced side effects via the combined use of an autophagy inhibitor. ACADL: acyl-Coenzyme A dehydrogenase, long-chain; ACADM: acyl-Coenzyme A dehydrogenase, medium-chain; ACADS: acyl-Coenzyme A dehydrogenase, short-chain; ADIPOQ: adiponectin; AGT: angiotensinogen; Atg: autophagy-related; BAT: brown adipose tissue; BTG1: B cell translocation gene 1, anti-proliferative; CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha; CIDEA: cell death-inducing DNA fragmentation factor, alpha subunit-like effector A; CPT1B: carnitine palmitoyltransferase 1b, muscle; CPT2: carnitine palmitoyltransferase 2; CQ: chloroquine; Dex: dexamethasone; eWAT: epididymal white adipose tissue; FABP4: fatty acid binding protein 4, adipocyte; FFAs: free fatty acids; GCs: glucocorticoids; NRIP1: nuclear receptor interacting protein 1; OCR: oxygen consumption rate; PBS: phosphate-buffered saline; PPARA: peroxisome proliferator activated receptor alpha; PPARG: peroxisome proliferator activated receptor gamma; PPARGC1A: peroxisome proliferator activated receptor, gamma, coactivator 1 alpha; PRDM16: PR domain containing 16; PSAT1: phosphoserine aminotransferase 1; RB1: RB transcriptional corepressor 1; RBL1/p107: RB transcriptional corepressor like 1; SQSTM1: sequestosome 1; sWAT: subcutaneous white adipose tissue; TG: triglycerides; UCP1: uncoupling protein 1 (mitochondrial, proton carrier); WT: wild-type
AbstractList The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell features defined as BAT whitening under certain circumstances. The aim of our current study was to investigate the possibility and mechanisms of GC-induced BAT whitening. Here, we showed that one-week dexamethasone (Dex) treatment induced BAT whitening, characterized by lipid droplet accumulation, in vitro and in vivo. Furthermore, autophagy and ATG7 (autophagy related 7) expression was induced in BAT by Dex, and treatment with the autophagy inhibitor chloroquine or adenovirus-mediated ATG7 knockdown prevented Dex-induced BAT whitening and fat mass gain. Moreover, Dex-increased ATG7 expression and autophagy was mediated by enhanced expression of BTG1 (B cell translocation gene 1, anti-proliferative) that stimulated activity of CREB1 (cAMP response element binding protein 1). The importance of BTG1 in this regulation was further demonstrated by the observed BAT whitening in adipocyte-specific BTG1-overexpressing mice and the attenuated Dex-induced BAT whitening and fat mass gain in mice with BTG1 knockdown in BAT. Taken together, we showed that Dex induces a significant whitening of BAT via BTG1- and ATG7-dependent autophagy, which might contribute to Dex-increased adiposity. These results provide new insights into the mechanisms underlying GC-increased adiposity and possible strategy for preventing GC-induced side effects via the combined use of an autophagy inhibitor. ACADL: acyl-Coenzyme A dehydrogenase, long-chain; ACADM: acyl-Coenzyme A dehydrogenase, medium-chain; ACADS: acyl-Coenzyme A dehydrogenase, short-chain; ADIPOQ: adiponectin; AGT: angiotensinogen; Atg: autophagy-related; BAT: brown adipose tissue; BTG1: B cell translocation gene 1, anti-proliferative; CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha; CIDEA: cell death-inducing DNA fragmentation factor, alpha subunit-like effector A; CPT1B: carnitine palmitoyltransferase 1b, muscle; CPT2: carnitine palmitoyltransferase 2; CQ: chloroquine; Dex: dexamethasone; eWAT: epididymal white adipose tissue; FABP4: fatty acid binding protein 4, adipocyte; FFAs: free fatty acids; GCs: glucocorticoids; NRIP1: nuclear receptor interacting protein 1; OCR: oxygen consumption rate; PBS: phosphate-buffered saline; PPARA: peroxisome proliferator activated receptor alpha; PPARG: peroxisome proliferator activated receptor gamma; PPARGC1A: peroxisome proliferator activated receptor, gamma, coactivator 1 alpha; PRDM16: PR domain containing 16; PSAT1: phosphoserine aminotransferase 1; RB1: RB transcriptional corepressor 1; RBL1/p107: RB transcriptional corepressor like 1; SQSTM1: sequestosome 1; sWAT: subcutaneous white adipose tissue; TG: triglycerides; UCP1: uncoupling protein 1 (mitochondrial, proton carrier); WT: wild-type.
The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell features defined as BAT whitening under certain circumstances. The aim of our current study was to investigate the possibility and mechanisms of GC-induced BAT whitening. Here, we showed that one-week dexamethasone (Dex) treatment induced BAT whitening, characterized by lipid droplet accumulation, in vitro and in vivo. Furthermore, autophagy and ATG7 (autophagy related 7) expression was induced in BAT by Dex, and treatment with the autophagy inhibitor chloroquine or adenovirus-mediated ATG7 knockdown prevented Dex-induced BAT whitening and fat mass gain. Moreover, Dex-increased ATG7 expression and autophagy was mediated by enhanced expression of BTG1 (B cell translocation gene 1, anti-proliferative) that stimulated activity of CREB1 (cAMP response element binding protein 1). The importance of BTG1 in this regulation was further demonstrated by the observed BAT whitening in adipocyte-specific BTG1-overexpressing mice and the attenuated Dex-induced BAT whitening and fat mass gain in mice with BTG1 knockdown in BAT. Taken together, we showed that Dex induces a significant whitening of BAT via BTG1- and ATG7-dependent autophagy, which might contribute to Dex-increased adiposity. These results provide new insights into the mechanisms underlying GC-increased adiposity and possible strategy for preventing GC-induced side effects via the combined use of an autophagy inhibitor. Abbreviations: ACADL: acyl-Coenzyme A dehydrogenase, long-chain; ACADM: acyl-Coenzyme A dehydrogenase, medium-chain; ACADS: acyl-Coenzyme A dehydrogenase, short-chain; ADIPOQ: adiponectin; AGT: angiotensinogen; Atg: autophagy-related; BAT: brown adipose tissue; BTG1: B cell translocation gene 1, anti-proliferative; CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha; CIDEA: cell death-inducing DNA fragmentation factor, alpha subunit-like effector A; CPT1B: carnitine palmitoyltransferase 1b, muscle; CPT2: carnitine palmitoyltransferase 2; CQ: chloroquine; Dex: dexamethasone; eWAT: epididymal white adipose tissue; FABP4: fatty acid binding protein 4, adipocyte; FFAs: free fatty acids; GCs: glucocorticoids; NRIP1: nuclear receptor interacting protein 1; OCR: oxygen consumption rate; PBS: phosphate-buffered saline; PPARA: peroxisome proliferator activated receptor alpha; PPARG: peroxisome proliferator activated receptor gamma; PPARGC1A: peroxisome proliferator activated receptor, gamma, coactivator 1 alpha; PRDM16: PR domain containing 16; PSAT1: phosphoserine aminotransferase 1; RB1: RB transcriptional corepressor 1; RBL1/p107: RB transcriptional corepressor like 1; SQSTM1: sequestosome 1; sWAT: subcutaneous white adipose tissue; TG: triglycerides; UCP1: uncoupling protein 1 (mitochondrial, proton carrier); WT: wild-type
The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell features defined as BAT whitening under certain circumstances. The aim of our current study was to investigate the possibility and mechanisms of GC-induced BAT whitening. Here, we showed that one-week dexamethasone (Dex) treatment induced BAT whitening, characterized by lipid droplet accumulation, in vitro and in vivo. Furthermore, autophagy and ATG7 (autophagy related 7) expression was induced in BAT by Dex, and treatment with the autophagy inhibitor chloroquine or adenovirus-mediated ATG7 knockdown prevented Dex-induced BAT whitening and fat mass gain. Moreover, Dex-increased ATG7 expression and autophagy was mediated by enhanced expression of BTG1 (B cell translocation gene 1, anti-proliferative) that stimulated activity of CREB1 (cAMP response element binding protein 1). The importance of BTG1 in this regulation was further demonstrated by the observed BAT whitening in adipocyte-specific BTG1-overexpressing mice and the attenuated Dex-induced BAT whitening and fat mass gain in mice with BTG1 knockdown in BAT. Taken together, we showed that Dex induces a significant whitening of BAT via BTG1- and ATG7-dependent autophagy, which might contribute to Dex-increased adiposity. These results provide new insights into the mechanisms underlying GC-increased adiposity and possible strategy for preventing GC-induced side effects via the combined use of an autophagy inhibitor.Abbreviations: ACADL: acyl-Coenzyme A dehydrogenase, long-chain; ACADM: acyl-Coenzyme A dehydrogenase, medium-chain; ACADS: acyl-Coenzyme A dehydrogenase, short-chain; ADIPOQ: adiponectin; AGT: angiotensinogen; Atg: autophagy-related; BAT: brown adipose tissue; BTG1: B cell translocation gene 1, anti-proliferative; CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha; CIDEA: cell death-inducing DNA fragmentation factor, alpha subunit-like effector A; CPT1B: carnitine palmitoyltransferase 1b, muscle; CPT2: carnitine palmitoyltransferase 2; CQ: chloroquine; Dex: dexamethasone; eWAT: epididymal white adipose tissue; FABP4: fatty acid binding protein 4, adipocyte; FFAs: free fatty acids; GCs: glucocorticoids; NRIP1: nuclear receptor interacting protein 1; OCR: oxygen consumption rate; PBS: phosphate-buffered saline; PPARA: peroxisome proliferator activated receptor alpha; PPARG: peroxisome proliferator activated receptor gamma; PPARGC1A: peroxisome proliferator activated receptor, gamma, coactivator 1 alpha; PRDM16: PR domain containing 16; PSAT1: phosphoserine aminotransferase 1; RB1: RB transcriptional corepressor 1; RBL1/p107: RB transcriptional corepressor like 1; SQSTM1: sequestosome 1; sWAT: subcutaneous white adipose tissue; TG: triglycerides; UCP1: uncoupling protein 1 (mitochondrial, proton carrier); WT: wild-type.The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell features defined as BAT whitening under certain circumstances. The aim of our current study was to investigate the possibility and mechanisms of GC-induced BAT whitening. Here, we showed that one-week dexamethasone (Dex) treatment induced BAT whitening, characterized by lipid droplet accumulation, in vitro and in vivo. Furthermore, autophagy and ATG7 (autophagy related 7) expression was induced in BAT by Dex, and treatment with the autophagy inhibitor chloroquine or adenovirus-mediated ATG7 knockdown prevented Dex-induced BAT whitening and fat mass gain. Moreover, Dex-increased ATG7 expression and autophagy was mediated by enhanced expression of BTG1 (B cell translocation gene 1, anti-proliferative) that stimulated activity of CREB1 (cAMP response element binding protein 1). The importance of BTG1 in this regulation was further demonstrated by the observed BAT whitening in adipocyte-specific BTG1-overexpressing mice and the attenuated Dex-induced BAT whitening and fat mass gain in mice with BTG1 knockdown in BAT. Taken together, we showed that Dex induces a significant whitening of BAT via BTG1- and ATG7-dependent autophagy, which might contribute to Dex-increased adiposity. These results provide new insights into the mechanisms underlying GC-increased adiposity and possible strategy for preventing GC-induced side effects via the combined use of an autophagy inhibitor.Abbreviations: ACADL: acyl-Coenzyme A dehydrogenase, long-chain; ACADM: acyl-Coenzyme A dehydrogenase, medium-chain; ACADS: acyl-Coenzyme A dehydrogenase, short-chain; ADIPOQ: adiponectin; AGT: angiotensinogen; Atg: autophagy-related; BAT: brown adipose tissue; BTG1: B cell translocation gene 1, anti-proliferative; CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha; CIDEA: cell death-inducing DNA fragmentation factor, alpha subunit-like effector A; CPT1B: carnitine palmitoyltransferase 1b, muscle; CPT2: carnitine palmitoyltransferase 2; CQ: chloroquine; Dex: dexamethasone; eWAT: epididymal white adipose tissue; FABP4: fatty acid binding protein 4, adipocyte; FFAs: free fatty acids; GCs: glucocorticoids; NRIP1: nuclear receptor interacting protein 1; OCR: oxygen consumption rate; PBS: phosphate-buffered saline; PPARA: peroxisome proliferator activated receptor alpha; PPARG: peroxisome proliferator activated receptor gamma; PPARGC1A: peroxisome proliferator activated receptor, gamma, coactivator 1 alpha; PRDM16: PR domain containing 16; PSAT1: phosphoserine aminotransferase 1; RB1: RB transcriptional corepressor 1; RBL1/p107: RB transcriptional corepressor like 1; SQSTM1: sequestosome 1; sWAT: subcutaneous white adipose tissue; TG: triglycerides; UCP1: uncoupling protein 1 (mitochondrial, proton carrier); WT: wild-type.
The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell features defined as BAT whitening under certain circumstances. The aim of our current study was to investigate the possibility and mechanisms of GC-induced BAT whitening. Here, we showed that one-week dexamethasone (Dex) treatment induced BAT whitening, characterized by lipid droplet accumulation, in vitro and in vivo. Furthermore, autophagy and ATG7 (autophagy related 7) expression was induced in BAT by Dex, and treatment with the autophagy inhibitor chloroquine or adenovirus-mediated ATG7 knockdown prevented Dex-induced BAT whitening and fat mass gain. Moreover, Dex-increased ATG7 expression and autophagy was mediated by enhanced expression of BTG1 (B cell translocation gene 1, anti-proliferative) that stimulated activity of CREB1 (cAMP response element binding protein 1). The importance of BTG1 in this regulation was further demonstrated by the observed BAT whitening in adipocyte-specific BTG1-overexpressing mice and the attenuated Dex-induced BAT whitening and fat mass gain in mice with BTG1 knockdown in BAT. Taken together, we showed that Dex induces a significant whitening of BAT via BTG1- and ATG7-dependent autophagy, which might contribute to Dex-increased adiposity. These results provide new insights into the mechanisms underlying GC-increased adiposity and possible strategy for preventing GC-induced side effects via the combined use of an autophagy inhibitor. ACADL: acyl-Coenzyme A dehydrogenase, long-chain; ACADM: acyl-Coenzyme A dehydrogenase, medium-chain; ACADS: acyl-Coenzyme A dehydrogenase, short-chain; ADIPOQ: adiponectin; AGT: angiotensinogen; Atg: autophagy-related; BAT: brown adipose tissue; BTG1: B cell translocation gene 1, anti-proliferative; CEBPA: CCAAT/enhancer binding protein (C/EBP), alpha; CIDEA: cell death-inducing DNA fragmentation factor, alpha subunit-like effector A; CPT1B: carnitine palmitoyltransferase 1b, muscle; CPT2: carnitine palmitoyltransferase 2; CQ: chloroquine; Dex: dexamethasone; eWAT: epididymal white adipose tissue; FABP4: fatty acid binding protein 4, adipocyte; FFAs: free fatty acids; GCs: glucocorticoids; NRIP1: nuclear receptor interacting protein 1; OCR: oxygen consumption rate; PBS: phosphate-buffered saline; PPARA: peroxisome proliferator activated receptor alpha; PPARG: peroxisome proliferator activated receptor gamma; PPARGC1A: peroxisome proliferator activated receptor, gamma, coactivator 1 alpha; PRDM16: PR domain containing 16; PSAT1: phosphoserine aminotransferase 1; RB1: RB transcriptional corepressor 1; RBL1/p107: RB transcriptional corepressor like 1; SQSTM1: sequestosome 1; sWAT: subcutaneous white adipose tissue; TG: triglycerides; UCP1: uncoupling protein 1 (mitochondrial, proton carrier); WT: wild-type
Author Guo, Yajie
Yuan, Feixiang
Zhai, Qiwei
Jiao, Fuxin
Guo, Feifan
Yin, Hanrui
Ying, Hao
Chen, Yan
Chen, Shanghai
Xiao, Fei
Wang, Fenfen
Ji, Hongbin
Deng, Jiali
Jiang, Xiaoxue
Hu, Guohong
Author_xml – sequence: 1
  givenname: Jiali
  surname: Deng
  fullname: Deng, Jiali
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 2
  givenname: Yajie
  surname: Guo
  fullname: Guo, Yajie
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 3
  givenname: Feixiang
  surname: Yuan
  fullname: Yuan, Feixiang
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 4
  givenname: Shanghai
  surname: Chen
  fullname: Chen, Shanghai
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 5
  givenname: Hanrui
  surname: Yin
  fullname: Yin, Hanrui
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 6
  givenname: Xiaoxue
  surname: Jiang
  fullname: Jiang, Xiaoxue
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 7
  givenname: Fuxin
  surname: Jiao
  fullname: Jiao, Fuxin
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 8
  givenname: Fenfen
  surname: Wang
  fullname: Wang, Fenfen
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 9
  givenname: Hongbin
  orcidid: 0000-0003-0891-6390
  surname: Ji
  fullname: Ji, Hongbin
  organization: Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 10
  givenname: Guohong
  orcidid: 0000-0002-2980-5166
  surname: Hu
  fullname: Hu, Guohong
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine
– sequence: 11
  givenname: Hao
  surname: Ying
  fullname: Ying, Hao
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 12
  givenname: Yan
  orcidid: 0000-0002-6630-0693
  surname: Chen
  fullname: Chen, Yan
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 13
  givenname: Qiwei
  surname: Zhai
  fullname: Zhai, Qiwei
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 14
  givenname: Fei
  surname: Xiao
  fullname: Xiao, Fei
  email: xiaofei@sibs.ac.cn
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
– sequence: 15
  givenname: Feifan
  surname: Guo
  fullname: Guo, Feifan
  email: ffguo@sibs.ac.cn
  organization: Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31184563$$D View this record in MEDLINE/PubMed
BookMark eNqFUUuP0zAQttAi9gE_AZQjl3T9iB1HSIjuCliklbgsVyzHsdtBqR1sp6v-e1y1XQEHOI3H8z1G812iMx-8Reg1wQuCJb4mnDdS0HZBMekWRFDJWfsMXez_aykYP3t60_YcXab0A2MmZEdfoHNGiGy4YBfo-3LOYVrr1a4Cv4YeMgRfTdFurc-pWo2zCSbEDCbAUIM30epkh0oPMIUEeVdtQVdpngolJfCr6mb5UD2uIVtfupfoudNjsq-O9Qp9-_Tx4fauvv_6-cvt8r42nDW5bsWA-05zTUWriey1kcbigTnc8p63hlqsG8fL3BGGpSOaYdbg1sneEEcku0LvD7rT3G_sYMryUY9qirDRcaeCBvXnxMNarcJWia7rBOmKwNujQAw_Z5uy2kAydhy1t2FOitKGNZJSJgr0ze9eTyanoxbAuwPAxJBStE4ZyHp_2GINoyJY7SNUpwjVPkJ1jLCw-V_sk8H_eB8OPPAuxI1-DHEcVNa7MUQXtTeQyor_lPgF6HS1iA
CitedBy_id crossref_primary_10_1002_jcp_31397
crossref_primary_10_1016_j_isci_2024_108857
crossref_primary_10_1038_s41467_024_52059_1
crossref_primary_10_3390_biomedicines9111651
crossref_primary_10_1002_advs_202308968
crossref_primary_10_1177_09645284211056345
crossref_primary_10_1038_s41467_023_38141_0
crossref_primary_10_3389_fendo_2024_1404697
crossref_primary_10_3389_fendo_2023_1114767
crossref_primary_10_3390_antiox11081505
crossref_primary_10_1016_j_celrep_2023_113504
crossref_primary_10_3389_fendo_2020_592818
crossref_primary_10_1186_s12906_022_03622_0
crossref_primary_10_3389_fgene_2019_01320
crossref_primary_10_1016_j_ebiom_2021_103713
crossref_primary_10_1096_fj_202001550R
crossref_primary_10_3390_ani14060899
crossref_primary_10_3390_pharmaceutics14061192
crossref_primary_10_1080_26895293_2022_2156623
crossref_primary_10_1111_apha_13793
crossref_primary_10_1016_j_cmet_2023_03_019
crossref_primary_10_1016_j_jnutbio_2024_109688
crossref_primary_10_1016_j_ecoenv_2022_113173
crossref_primary_10_1016_j_bbalip_2022_159111
crossref_primary_10_3389_fendo_2023_1191278
crossref_primary_10_3390_ijms22168503
crossref_primary_10_1016_j_yexcr_2025_114478
crossref_primary_10_3390_ijms25094588
crossref_primary_10_1007_s12020_024_04008_7
crossref_primary_10_1097_TP_0000000000004862
crossref_primary_10_1080_21623945_2022_2111053
crossref_primary_10_1016_j_hrthm_2022_07_030
crossref_primary_10_1155_2024_6822664
crossref_primary_10_1096_fj_202200870R
crossref_primary_10_1016_j_jnutbio_2022_109160
crossref_primary_10_1111_jne_13248
crossref_primary_10_3390_metabo12010084
crossref_primary_10_1111_obr_13724
crossref_primary_10_1038_s41556_023_01155_3
crossref_primary_10_1016_j_jff_2025_106758
crossref_primary_10_1007_s40618_023_02295_x
crossref_primary_10_1038_s41419_021_04187_5
crossref_primary_10_12677_ACM_2024_142366
crossref_primary_10_1016_j_molmet_2022_101446
crossref_primary_10_3390_ijms232415761
crossref_primary_10_1002_lipd_12358
crossref_primary_10_1186_s40104_024_00994_w
crossref_primary_10_1002_advs_202205854
crossref_primary_10_1016_j_heliyon_2024_e27314
crossref_primary_10_3389_fendo_2020_565483
crossref_primary_10_1016_j_molmet_2024_101884
crossref_primary_10_3389_fimmu_2023_1157731
crossref_primary_10_1111_obr_13691
Cites_doi 10.1074/jbc.275.1.147
10.1016/j.cmet.2016.06.011
10.1128/MCB.00193-13
10.1002/jcp.21919
10.1056/NEJMra050541
10.1172/JCI71643
10.4161/adip.29674
10.1016/j.cmet.2016.08.002
10.2337/db15-1024
10.1016/j.tem.2011.02.003
10.1038/nature13949
10.1016/S0006-291X(02)00361-3
10.1073/pnas.1320454110
10.1093/rheumatology/kew348
10.4161/auto.5.8.9991
10.1038/nm.3361
10.1126/science.1175667
10.1152/ajpendo.00640.2012
10.1038/nrm4024
10.1002/j.1460-2075.1992.tb05213.x
10.1038/s41586-018-0353-2
10.2337/db14-0427
10.1016/j.celrep.2014.12.023
10.1126/scisignal.aap8526
10.1016/j.celrep.2016.09.053
10.1210/en.2006-0267
10.1074/jbc.M115.686980
10.1182/blood-2003-03-0923
10.1074/jbc.271.25.15034
10.1038/embor.2013.111
10.1038/ncb2286
10.1016/j.cmet.2016.04.023
10.1038/ijo.2016.115
10.2337/db13-0311
10.4161/cc.29272
10.1126/scisignal.aad8581
10.1002/jbmr.160
10.1073/pnas.1601281113
10.1016/S0014-5793(01)02436-X
10.1073/pnas.0906048106
10.1038/ijo.2010.180
10.1016/j.cmet.2010.04.005
10.1016/j.molcel.2016.09.037
10.1016/0092-8674(94)90400-6
10.1146/annurev-cellbio-092910-154005
10.1016/j.freeradbiomed.2005.07.017
10.1038/sj.onc.1208373
ContentType Journal Article
Copyright 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
2019 Informa UK Limited, trading as Taylor & Francis Group 2019 Informa UK Limited, trading as Taylor & Francis Group
Copyright_xml – notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019
– notice: 2019 Informa UK Limited, trading as Taylor & Francis Group 2019 Informa UK Limited, trading as Taylor & Francis Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1080/15548627.2019.1628537
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate J. DENG ET AL
EISSN 1554-8635
EndPage 465
ExternalDocumentID PMC6999619
31184563
10_1080_15548627_2019_1628537
1628537
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: ;
  grantid: 16JC1404900
– fundername: ;
  grantid: 17XD1404200
GroupedDBID ---
0BK
0R~
23N
30N
4.4
53G
5GY
AAJMT
AALDU
AAMIU
AAPUL
AAQRR
ABCCY
ABFIM
ABJNI
ABLIJ
ABPAQ
ABPEM
ABTAI
ABXUL
ABXYU
ACGFS
ACTIO
ADBBV
ADCVX
ADGTB
AEISY
AENEX
AEYOC
AGDLA
AHDZW
AIJEM
AKBVH
AKOOK
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AOIJS
AQRUH
AVBZW
AWYRJ
BAWUL
BLEHA
CCCUG
DGEBU
DIK
DKSSO
E3Z
EBS
EMOBN
F5P
GTTXZ
H13
HYE
IPNFZ
KYCEM
LJTGL
M4Z
O9-
OK1
P2P
RIG
RNANH
ROSJB
RPM
RTWRZ
SNACF
TBQAZ
TDBHL
TEI
TFL
TFT
TFW
TQWBC
TR2
TTHFI
TUROJ
ZGOLN
AAGDL
AAHIA
AAYXX
ADHGD
ADYSH
AFRVT
AIYEW
AMPGV
CITATION
AAGME
ABFMO
ACDHJ
ACZPZ
ADOPC
AURDB
BFWEY
C1A
CGR
CUY
CVF
CWRZV
ECM
EIF
EJD
NPM
PCLFJ
TASJS
7X8
5PM
ID FETCH-LOGICAL-c534t-76d0b9a5a267a18bac8ce0d3f075b57c2e0a4f55a2f1308f1a303407f8bc1f183
ISSN 1554-8627
1554-8635
IngestDate Thu Aug 21 14:11:41 EDT 2025
Fri Jul 11 02:14:15 EDT 2025
Mon Jul 21 05:28:14 EDT 2025
Thu Apr 24 23:10:16 EDT 2025
Tue Jul 01 02:48:58 EDT 2025
Wed Dec 25 09:09:44 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords glucocorticoid
BAT whitening
BTG1
autophagy
ATG7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c534t-76d0b9a5a267a18bac8ce0d3f075b57c2e0a4f55a2f1308f1a303407f8bc1f183
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Lead C ontact
ORCID 0000-0003-0891-6390
0000-0002-6630-0693
0000-0002-2980-5166
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.1080/15548627.2019.1628537?needAccess=true
PMID 31184563
PQID 2243482236
PQPubID 23479
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6999619
crossref_citationtrail_10_1080_15548627_2019_1628537
crossref_primary_10_1080_15548627_2019_1628537
pubmed_primary_31184563
informaworld_taylorfrancis_310_1080_15548627_2019_1628537
proquest_miscellaneous_2243482236
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-03-03
PublicationDateYYYYMMDD 2020-03-03
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-03
  day: 03
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Autophagy
PublicationTitleAlternate Autophagy
PublicationYear 2020
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References cit0033
cit0034
cit0031
cit0032
cit0030
cit0039
cit0037
cit0038
cit0035
cit0036
cit0022
cit0020
cit0021
cit0028
cit0029
cit0026
cit0027
cit0024
cit0025
cit0011
cit0012
cit0010
cit0051
cit0050
Strack AM (cit0006) 1995; 268
cit0019
cit0017
cit0015
Moriscot A (cit0005) 1993; 265
cit0016
cit0013
cit0014
cit0044
cit0001
cit0045
cit0042
cit0043
cit0040
cit0041
Singh R (cit0018) 2009; 119
Duriez C (cit0023) 2004; 91
cit0008
cit0009
cit0007
cit0004
cit0048
cit0049
cit0002
cit0046
cit0003
cit0047
References_xml – ident: cit0042
  doi: 10.1074/jbc.275.1.147
– ident: cit0008
  doi: 10.1016/j.cmet.2016.06.011
– ident: cit0048
  doi: 10.1128/MCB.00193-13
– ident: cit0021
  doi: 10.1002/jcp.21919
– ident: cit0001
  doi: 10.1056/NEJMra050541
– ident: cit0009
  doi: 10.1172/JCI71643
– ident: cit0044
  doi: 10.4161/adip.29674
– ident: cit0036
  doi: 10.1016/j.cmet.2016.08.002
– volume: 268
  start-page: R183
  issue: 1
  year: 1995
  ident: cit0006
  publication-title: A J Physiol
– ident: cit0033
  doi: 10.2337/db15-1024
– ident: cit0013
  doi: 10.1016/j.tem.2011.02.003
– ident: cit0035
  doi: 10.1038/nature13949
– ident: cit0025
  doi: 10.1016/S0006-291X(02)00361-3
– ident: cit0004
  doi: 10.1073/pnas.1320454110
– ident: cit0002
  doi: 10.1093/rheumatology/kew348
– volume: 265
  start-page: E81
  issue: 1
  year: 1993
  ident: cit0005
  publication-title: A J Physiol
– ident: cit0014
  doi: 10.4161/auto.5.8.9991
– ident: cit0007
  doi: 10.1038/nm.3361
– volume: 91
  start-page: E242
  issue: 7
  year: 2004
  ident: cit0023
  publication-title: Bull Cancer
– ident: cit0038
  doi: 10.1126/science.1175667
– ident: cit0046
  doi: 10.1152/ajpendo.00640.2012
– volume: 119
  start-page: 3329
  issue: 11
  year: 2009
  ident: cit0018
  publication-title: J Clin Invest
– ident: cit0012
  doi: 10.1038/nrm4024
– ident: cit0022
  doi: 10.1002/j.1460-2075.1992.tb05213.x
– ident: cit0050
  doi: 10.1038/s41586-018-0353-2
– ident: cit0010
  doi: 10.2337/db14-0427
– ident: cit0031
  doi: 10.1016/j.celrep.2014.12.023
– ident: cit0037
  doi: 10.1126/scisignal.aap8526
– ident: cit0011
  doi: 10.1016/j.celrep.2016.09.053
– ident: cit0003
  doi: 10.1210/en.2006-0267
– ident: cit0030
  doi: 10.1074/jbc.M115.686980
– ident: cit0026
  doi: 10.1182/blood-2003-03-0923
– ident: cit0041
  doi: 10.1074/jbc.271.25.15034
– ident: cit0017
  doi: 10.1038/embor.2013.111
– ident: cit0029
  doi: 10.1038/ncb2286
– ident: cit0051
  doi: 10.1016/j.cmet.2016.04.023
– ident: cit0016
  doi: 10.1038/ijo.2016.115
– ident: cit0047
  doi: 10.2337/db13-0311
– ident: cit0020
  doi: 10.4161/cc.29272
– ident: cit0027
  doi: 10.1126/scisignal.aad8581
– ident: cit0019
  doi: 10.1002/jbmr.160
– ident: cit0028
  doi: 10.1073/pnas.1601281113
– ident: cit0024
  doi: 10.1016/S0014-5793(01)02436-X
– ident: cit0015
  doi: 10.1073/pnas.0906048106
– ident: cit0045
  doi: 10.1038/ijo.2010.180
– ident: cit0032
  doi: 10.1016/j.cmet.2010.04.005
– ident: cit0049
  doi: 10.1016/j.molcel.2016.09.037
– ident: cit0043
  doi: 10.1016/0092-8674(94)90400-6
– ident: cit0034
  doi: 10.1146/annurev-cellbio-092910-154005
– ident: cit0040
  doi: 10.1016/j.freeradbiomed.2005.07.017
– ident: cit0039
  doi: 10.1038/sj.onc.1208373
SSID ssj0036892
Score 2.5064077
Snippet The mechanisms underlying glucocorticoid (GC)-increased adiposity are poorly understood. Brown adipose tissue (BAT) acquires white adipose tissue (WAT) cell...
SourceID pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 451
SubjectTerms Adipogenesis - drug effects
Adipose Tissue, Brown - drug effects
Adipose Tissue, Brown - metabolism
Adipose Tissue, White - drug effects
Adipose Tissue, White - metabolism
Adiposity - drug effects
Animals
Animals, Newborn
ATG7
Autophagy
Autophagy-Related Protein 7 - genetics
Autophagy-Related Protein 7 - metabolism
BAT whitening
BTG1
Cell Line
Cyclic AMP Response Element-Binding Protein - metabolism
Dexamethasone - pharmacology
Gene Expression Regulation - drug effects
Gene Knockdown Techniques
glucocorticoid
Glucocorticoids - pharmacology
Humans
Lipids - chemistry
Male
Mice, Inbred C57BL
Mice, Transgenic
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Research Paper
Title Autophagy inhibition prevents glucocorticoid-increased adiposity via suppressing BAT whitening
URI https://www.tandfonline.com/doi/abs/10.1080/15548627.2019.1628537
https://www.ncbi.nlm.nih.gov/pubmed/31184563
https://www.proquest.com/docview/2243482236
https://pubmed.ncbi.nlm.nih.gov/PMC6999619
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahY6MvZfelu-DB3oIzx5J8eSxlpQxaBkuhfZmRZLlR2Zyw2N26n7FfvCPJVpQ2o1tfTLAjy_b5fPQd-TtHCL3jnFSplDjMEpGHRFARMqDFISWcsSRiuTSS_6Pj5PCEfDylp4PBb0-11DZ8LH5tzCu5i1VhH9hVZ8n-h2XdSWEH_Ab7whYsDNt_svFeq8sCMJO7N1PcqK901v-lSVszanQILqHZXJWhqjVBXALBZKUyWq2r0aVio2W7sGLY-hyi9unoh_6wUPcj2sW1nhzxlZ2UF-5SORFPayZez9iFcng5a-0U64FUPwGK5ys9gXV4n_WM9Ywpf_oBYk2tv8IOMNMbK4H4zpQSwIDN_R9Lf58tUeI8cOIhDXvulHTFaO3ITOyqEjecvlVJ6jPrzrRcLx9PdGqoLSfjAWHxzSABQ1QFxBGvxkCnTPx0tJ_oGFBXkr0XQ-ihfSeOjvvRHSeZWWjb3VufFZZF7zdewTZ60He3Rn3WCuNuCm-uq3Q92jN9iHa6eCXYs-B7hAayfozu2xVMr56gLw4YwQqCQQ_B4G8QDBwEA4Bg4EEwAAgGDoJP0cnBh-n-Ydgt2REKikkTpkkZ8ZxRFicpm2SciUzIqMQVMFNOUxHLiJGKwvEKyFNWTRhQKBKlVcbFpILh5Rnaque1fIGCmAoIxeG0KTCoKBKMJoQLVqVlVsWE0iEi_dMsRFfPXi-r8rWYdGVve3sU2h5FZ48hGrtmC1vQ5bYGuW-qojGIryzYC3xL27e9XQtw2_pbHKvlvF0WwJx1WakYJ0P03NrZXU6PlyFK1xDg_qBLwq8fqdXMlIbvsLt755Yv0fbqLX-FtprvrXwNtLvhb8x78AcKZ9WL
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIgQX3tDlaSQ4ZpvEsZMcOCyPakvbPW2lngi2Y7cRVXbFJlTLz-Kv8IeYyWPVrUA9oB44J44m8cz4G-fzNwCvtY5cbC33EmlSLzLCeAphsScirZT0VWobyv_BRI4Po09H4mgDfvZnYYhWSTW0a4UimlxNwU2b0T0lbpvWQETiMTGz0mFApwB53BEr9-zyDMu2xdvdDzjHb8Jw5-P0_djrOgt4RvCo8mKZ-zpVQoUyVkGilUmM9XPucAHVIjah9VXkBF53mOMTFyjM9Fj6uESbwGEU4HOvwXWRyphii_uTPvtzmTSNmMlEj2zsTw39zey19XBNLfVPmPcidfPcWrhzB371X7GlwHwd1pUemh8XBCb_r898F2530JyN2li6Bxu2vA832madywfweVSTCIM6XrKiPCl0w3Vj81YCa8Ea7j-W8jh4VuReURIcX9icqbxomHFL9r1QbFHPW-pxeczejabsjH7j0N7UQzi8kpd7BJvlrLRbwEJhsOrEx8YIFnzfKCEjbZSL88SFkRADiHofyUwn3U4dRE6zoFN47acqo6nKuqkawHA1bN5ql1w2ID3vgFnVbBq5tsNLxi8Z-6r31gwzFP12UqWd1YsMQSIpKIVcDuBx670rczjWtwjh-QDiNb9e3UDq5-tXyuKkUUGXVKoH6ZN_sPkl3BxPD_az_d3J3lO4FdJWCtEL-TPYrL7V9jnizUq_aAKcwZerdvXfUoqDSw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIhAX3o_laSQ4ZpvEsZMcOCyUVUthxaGVeiLYjt1GoOyKJFTLv-Kv8IuYyWPVrUA9oB44J44m8Xj8jfPNNwAvtI5cbC33EmlSLzLCeAphsScirZT0VWpbyv-Hmdw5iN4disMN-DnUwhCtknJo1wlFtLGaFvcidwMjbou2QATiMRGz0nFARYA87nmVe3Z5gllb9Wp3G6f4ZRhO3-6_2fH6xgKeETyqvVjmvk6VUKGMVZBoZRJj_Zw73D-1iE1ofRU5gdcdhvjEBQoDPWY-LtEmcLgI8LmX4LKkwk6qGvFnQ_DnMmn7MJOJHtk4FA39zey17XBNLPVPkPcsc_PUVji9Ab-Gj9gxYL6Mm1qPzY8z-pL_1Ve-Cdd7YM4m3Uq6BRu2vA1XuladyzvwadKQBIM6WrKiPC50y3Rji04Aq2It8x8TeRw8L3KvKAmMVzZnKi9aXtySfS8Uq5pFRzwuj9jryT47oZ84dDJ1Fw4u5OXuwWY5L-0DYKEwmHPiY2OECr5vlJCRNsrFeeLCSIgRRIOLZKYXbqf-IV-zoNd3HaYqo6nK-qkawXg1bNEpl5w3ID3tf1ndHhm5rr9Lxs8Z-3xw1gzjE_10UqWdN1WGEJH0k0IuR3C_c96VORyzWwTwfATxmluvbiDt8_UrZXHcaqBLStSD9OE_2PwMrn7cnmbvd2d7j-BaSOcoxC3kj2Gz_tbYJwg2a_20Xd4MPl-0p_8G-hOB7w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autophagy+inhibition+prevents+glucocorticoid-increased+adiposity+via+suppressing+BAT+whitening&rft.jtitle=Autophagy&rft.au=Deng%2C+Jiali&rft.au=Guo%2C+Yajie&rft.au=Yuan%2C+Feixiang&rft.au=Chen%2C+Shanghai&rft.date=2020-03-03&rft.pub=Taylor+%26+Francis&rft.issn=1554-8627&rft.eissn=1554-8635&rft.volume=16&rft.issue=3&rft.spage=451&rft.epage=465&rft_id=info:doi/10.1080%2F15548627.2019.1628537&rft_id=info%3Apmid%2F31184563&rft.externalDocID=PMC6999619
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1554-8627&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1554-8627&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1554-8627&client=summon